Willemze R, Beljaards R C, Rijlaarsdam U
Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.
Dermatol Clin. 1994 Apr;12(2):361-73.
Primary cutaneous large cell lymphomas represent a heterogeneous group of malignant lymphomas of T- and B-cell origin. Recent studies have been successful in delineating some well-defined clinicopathologic entities within this group. Primary cutaneous follicular (germinal) center cell lymphomas are the most common type of CBCL. These lymphomas generally present with localized skin lesions on the trunk or scalp. They have an indolent clinical course, are highly sensitive to radiotherapy, and have a favorable prognosis. Within the group of primary cutaneous T-LCL, distinction primarily should be made between CD30-positive (> 75% or large clusters of tumor cells) and CD30-negative (no or few scattered positive cells) T-LCL. Primary cutaneous CD30-positive T-LCL, which includes both anaplastic and non-anaplastic subtypes, have recently been defined as a distinct clinicopathologic entity with a favorable prognosis. The overlapping clinical and histological features with LyP suggest that both conditions are part of a broader spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Primary CD30-negative T-LCL generally are associated with a poor prognosis (4-year-survival, < 25%). Reports on this group are still few, however, and further studies are required to define subgroups with a more favorable prognosis within this heterogeneous group of lymphomas.
原发性皮肤大细胞淋巴瘤是一组起源于T细胞和B细胞的异质性恶性淋巴瘤。最近的研究成功地在该组中明确了一些定义明确的临床病理实体。原发性皮肤滤泡性(生发中心)细胞淋巴瘤是最常见的原发性皮肤大细胞淋巴瘤类型。这些淋巴瘤通常表现为躯干或头皮上的局限性皮肤病变。它们临床病程惰性,对放疗高度敏感,预后良好。在原发性皮肤T细胞淋巴瘤组中,主要应区分CD30阳性(>75%或肿瘤细胞大簇)和CD30阴性(无或少数散在阳性细胞)T细胞淋巴瘤。原发性皮肤CD30阳性T细胞淋巴瘤,包括间变性和非间变性亚型,最近被定义为一种预后良好的独特临床病理实体。与淋巴瘤样丘疹病重叠的临床和组织学特征表明,这两种情况都是原发性皮肤CD30阳性淋巴增殖性疾病更广泛谱系的一部分。原发性CD30阴性T细胞淋巴瘤通常预后较差(4年生存率<25%)。然而,关于该组的报道仍然很少,需要进一步研究以在这一异质性淋巴瘤组中确定预后更良好的亚组。